Appeals Court's Dismissal of Illumina Infringement Case Against Affy Could Impact BeadArray IP Suit | GenomeWeb

By Justin Petrone

The US Court of Appeals for the Federal Circuit has affirmed the dismissal of patent infringement lawsuits brought against Affymetrix by Illumina.

According to court documents, a court panel on Aug. 18 upheld an earlier decision by the US District Court for the Western District of Wisconsin that cleared Affy of infringing US Patent Nos. 7,510,841 and 7,612,020, which are owned by Illumina.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.